Latest current cash for SLRN: $58M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Acelyrin (SLRN) currently reports a current cash of $58M as of March 2025. That compares with $260M in the prior-year period — down 78.0% year over year. Use the charts on this page to explore Acelyrin's current cash history and peer comparisons.
Acelyrin's current cash decreased from $260M to $58M — a 78.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Acelyrin reported $58M in current cash as of March 2025. That compares with $260M in the prior-year period — down 78.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $58M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelyrin, and consider following SLRN for alerts when major investors trade the stock.